About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Study to Compare Two Formulations of CP-675,206 Monoclonal Antibody

Study to Compare Two Formulations of CP-675,206 Monoclonal Antibody

NCT00431275·8 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

AstraZeneca

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Stage III or Stage IV melanoma
No evidence of disease following resection of melanoma lesions
Recovered from all prior surgical or adjuvant treatment-related toxicities

You may not be if

History of chronic inflammatory or autoimmune disease
History of inflammatory bowel disease

The record

StatusCompleted

PhasePhase 1

Taking part85

StartedJun 2006

UpdatedJun 6, 2012

Conditions

Where8

Research Site
Scottsdale, Arizona, United States
Research Site
Aurora, Colorado, United States
Research Site
Aventura, Florida, United States